Analyst Price Target is $13.10
▲ +139.05% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for NeuroPace in the last 3 months. The average price target is $13.10, with a high forecast of $26.00 and a low forecast of $5.50. The average price target represents a 139.05% upside from the last price of $5.48.
Current Consensus is
The current consensus among 5 contributing investment analysts is to hold stock in NeuroPace. This rating has held steady since May 2022, when it changed from a Buy consensus rating.